TECHWIRE 30
(CIX: WRAL30)  1,091.08    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: Apple)  107.34    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NY: QUINTILES)  57.99    (0 %)  Updated: 06:40 PM EDT, Oct 29 2014
(OP: BASF SE)  86.58    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: BioCryst)  11.93    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: BioDelivery)  17.38    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: CEMP)  12.43    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: Cisco Systems)  24.10    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: Cree)  31.84    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: DARA)  0.88    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NY: EMC CORPORATION)  28.35    (0 %)  Updated: 06:40 PM EDT, Oct 29 2014
(NQ: Extreme Networks)  3.63    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: FB)  75.86    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NY: GLAXOSMITHKLINE)  45.08    (0 %)  Updated: 06:40 PM EDT, Oct 29 2014
(NQ: GOOG)  549.33    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NY: IBM)  163.46    (0 %)  Updated: 06:40 PM EDT, Oct 29 2014
(NY: LH)  106.70    (0 %)  Updated: 06:40 PM EDT, Oct 29 2014
(OP: Lenovo Group)  29.50    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NY: MRK)  56.20    (0 %)  Updated: 06:40 PM EDT, Oct 29 2014
(NQ: Microsoft Corp)  46.62    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: NTAP)  41.38    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NY: NOVARTIS AG)  91.31    (0 %)  Updated: 06:40 PM EDT, Oct 29 2014
(OP: Novozymes A/S)  45.39    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NY: PFIZER)  29.49    (0 %)  Updated: 06:40 PM EDT, Oct 29 2014
(NQ: Pozen)  8.74    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NY: RED HAT)  56.85    (0 %)  Updated: 06:40 PM EDT, Oct 29 2014
(NQ: BBRY)  10.51    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: Salix)  139.36    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014
(NQ: SQI)  16.33    (0 %)  Updated: 08:10 PM EDT, Oct 29 2014

Posts tagged “BDSI”

September 7, 2010

Premium Lock Former exec at Closure Medical joins BioDelivery Sciences

BDSI Benny Ward takes over as business and strategic development director at the drug delivery technology development firm.

May 10, 2010

Premium Lock BioDelivery Sciences wins Canadian approval for painkiller

BDSI The Raleigh-based firm can now sell its “breakthrough” pain killer drug outside of the U.S. It is seeking approval to sell Onsolis in Europe.

Updated April 20, 2010

Premium Lock BioDelivery Sciences stock plunges after $10M deal disclosed

BDSI The announced sale sends BDSI shares down 14 percent from Monday’s closing price of $4.21 per share.

September 2, 2009

Premium Lock BioDelivery Sciences closing lab in New Jersey, cutting five jobs

BDSI Chief science officer is also leaving drug development firm, which recently won FDA approval for its first product.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll